TFS Capital’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-379
| Closed | -$897K | – | 418 |
|
|
2017
Q2 | $897K | Buy |
379
+13
| +4% | +$30.8K | 0.35% | 71 |
|
|
2017
Q1 | $923K | Buy |
+366
| New | +$923K | 0.3% | 110 |
|
|
2016
Q3 | – | Sell |
-219
| Closed | -$671K | – | 1045 |
|
|
2016
Q2 | $671K | Buy |
219
+130
| +146% | +$398K | 0.12% | 287 |
|
|
2016
Q1 | $282K | Buy |
+89
| New | +$282K | 0.04% | 668 |
|
|
2015
Q4 | – | Sell |
-124
| Closed | -$395K | – | 950 |
|
|
2015
Q3 | $395K | Sell |
124
-312
| -72% | -$994K | 0.04% | 598 |
|
|
2015
Q2 | $1.75M | Sell |
436
-66
| -13% | -$264K | 0.17% | 186 |
|
|
2015
Q1 | $2M | Sell |
502
-414
| -45% | -$1.65M | 0.2% | 137 |
|
|
2014
Q4 | $4.49M | Buy |
916
+185
| +25% | +$907K | 0.43% | 26 |
|
|
2014
Q3 | $2.97M | Buy |
731
+457
| +167% | +$1.86M | 0.26% | 94 |
|
|
2014
Q2 | $1.11M | Buy |
274
+169
| +161% | +$685K | 0.09% | 371 |
|
|
2014
Q1 | $479K | Sell |
105
-143
| -58% | -$652K | 0.03% | 748 |
|
|
2013
Q4 | $869K | Buy |
+248
| New | +$869K | 0.04% | 606 |
|
|
2013
Q3 | – | Sell |
-213
| Closed | -$843K | – | 1669 |
|
|
2013
Q2 | $843K | Buy |
+213
| New | +$843K | 0.04% | 672 |
|